Let’s review the key information. Overall, the entire drug development process (from discovery to approval and marketing) can take 10-15 years or even longer. This timeline varies based on factors like the complexity of the disease being targeted; how efficiently clinical trials are run; how difficult it is to meet exacting regulatory requirements; and managing unforeseen challenges during the process. Conducting rigorous, careful science while patients’ lives hang in the balance is anything but fast and easy!
Here’s more on the drug development timeline:
1. Discovery and Preclinical Research (Knowledge Base)
This phase involves identifying a potential drug target, often a specific molecule or biological process associated with a disease. Researchers conduct extensive laboratory studies and experiments to understand the compound’s properties, mechanisms of action, and potential therapeutic effects.
Preclinical studies are performed using cell cultures and animal models to analyze safety signals, collect evidence of efficacy, and study potential side effects before moving a compound into human trials.
2. Investigational New Drug (IND) Application
Before a biotech or pharma company can test a drug in humans, its sponsor submits an IND application to the FDA. This application includes the key preclinical data and proposed clinical trial plan. Once the IND is approved, human clinical trials can begin.
(Continued on the next page…)